Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
19. November 2025
3 min to read

Artificial Intelligence Versus Human Expertise: ECG-Based Detection of Occlusive Myocardial Infarction After Cardiac Arrest

Overview

This single-centre study tested whether AI-based ECG analysis can detect occlusive myocardial infarction (OMI) after cardiac arrest using post-ROSC ECGs from 97 patients with subsequent coronary angiography. A dedicated deep neural network (Queen of Hearts, QoH) achieved the highest discrimination for acute coronary occlusion (AUC 0.85) and OMI (AUC 0.75), outperforming human experts, with a more balanced trade-off between sensitivity and specificity. In contrast, two large language model–based chatbots (ChatGPT and a GPT-based EKG Analyst) showed near-perfect sensitivity but almost no specificity, labelling nearly all ECGs as OMI and thus providing no meaningful diagnostic discrimination. These findings suggest that specialized ECG-trained AI, such as QoH, may serve as a useful adjunct in post-resuscitation decision-making. In contrast, general-purpose LLMs are currently unsuitable for critical ECG diagnosis.

Published in: Resuscitation
Published on: 19 November 2025

Background

Accurate electrocardiogram (ECG) interpretation after cardiac arrest is essential for identifying occlusive myocardial infarction (OMI), but post-resuscitation artifacts make this challenging. While artificial intelligence (AI) offers promising support, its diagnostic performance in this critical setting remains uncertain.

Methods

This single-centre study included 97 adult patients resuscitated from cardiac arrest (CA). Post-return of spontaneous circulation (ROSC), ECGs were evaluated by four methods: human experts (HE), a validated deep neural network (Queen of Hearts [QoH]), and two large language model (LLM)–based AI chatbots (AI-CB) – ChatGPT and EKG Analyst. The primary outcome was the AUROC for the presence and probability of OMI and acute coronary occlusion (ACO), determined by coronary angiography.

Results

For ACO (TIMI 0), QoH yielded the highest AUROC (0.846 [0.752–0.939]), followed by HE (0.735 [0.622 – 0.848]). Both AI-CB resulted in the lowest AUROC (ChatGPT: 0.456 [0.319 – 0.592]; EKG Analyst: 0.474 [0.346 – 0.603]. For OMI (TIMI 0-2 or TIMI 3 + peak-troponin), QoH again achieved the highest AUROC (0.745 [0.647 – 0.843]), followed by HE (0.635 [0.515 – 0.755]), AI-CB were lowest again (ChatGPT: 0.495 [0.376 – 0.614]; EKG Analyst: 0.626 [0.508 – 0.743]. Threshold-dependent performance metrics revealed high sensitivity (ACO: 100%; OMI: 98.36%) for both AI-CB, at the cost of minimal specificity. QoH and HE showed more even distributions of sensitivity/specificity.

Conclusion

QoH, despite operating without awareness of the CA-setting and thus likely at a relative disadvantage, and HE showed robust diagnostic accuracy. Due to undifferentiated overdiagnosis, general LLMs remain unsuitable for ECG interpretation. Domain-specific tools, such as QoH, may offer complementary value.

Artificial Intelligence Versus Human Expertise: ECG-Based Detection of Occlusive Myocardial Infarction After Cardiac Arrest
Authors: Claudio Silwanis, Johannes Eder, Alexander Fellner, Alexander Nahler, Max Groche, Hermann Blessberger, Jörg Kellermair, Anna Neunteufel, Maximilian Huss, Julian Maier, Clemens Steinwender, Thomas Lambert

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Artificial Intelligence Versus Human Expertise: ECG-Based Detection of Occlusive Myocardial Infarction After Cardiac Arrest

This single-centre study tested whether AI-based ECG analysis can detect occlusive myocardial infarction (OMI) after cardiac arrest using post-ROSC ECGs from 97 patients with subsequent coronary angiography. A dedicated deep neural network (Queen of Hearts, QoH) achieved the highest discrimination for acute coronary occlusion (AUC 0.85) and OMI (AUC 0.75), outperforming human experts, with a more balanced trade-off between sensitivity and specificity. In contrast, two large language model–based chatbots (ChatGPT and a GPT-based EKG Analyst) showed near-perfect sensitivity but almost no specificity, labelling nearly all ECGs as OMI and thus providing no meaningful diagnostic discrimination. These findings suggest that specialized ECG-trained AI, such as QoH, may serve as a useful adjunct in post-resuscitation decision-making. In contrast, general-purpose LLMs are currently unsuitable for critical ECG diagnosis.

Association Between Artificial Intelligence Detected Features on the ECG and Presence of Microvascular Obstruction

This study tested whether artificial intelligence (AI)–extracted electrocardiogram (ECG) features can identify microvascular obstruction (MVO) after reperfusion in anterior ST‑segment elevation myocardial infarction (STEMI). Using pre‑ and post‑percutaneous coronary intervention (PCI) ECGs and a logistic‑regression model built on PMcardio (API v2.5), the AI approach predicted CMR‑confirmed MVO with an AUC of 0.83, 94% specificity, and 60% sensitivity; the figure reports ~76% overall accuracy. By emphasizing high specificity, the model aims to flag patients very likely to harbor MVO when cardiac MRI is impractical, enabling rapid risk stratification at the point of care.

Join over 100,000 healthcare professionals who are already taking advantage of AI